Checkpoint Therapeutics (CKPT) - Uzoq muddatli qarzning kapitalga nisbati

Checkpoint Therapeutics (CKPT) tovar belgisi

Checkpoint Therapeutics (CKPT) laboratoriya sinovlarini raqamlashtirish uchun AI modellari va robototexnikani joriy etish orqali saratonga qarshi dori vositalarini kashf etishni tezlashtirmoqda. Hozirda tartibga soluvchi organlarning tasdig'ini kutayotgan hamyonbop teri terapiyasi analogining yaratilishi barqaror raqobatbardoshlikni ta'minlaydi. Aksiyalar narxining tarixi potentsiali kimyoterapiyasiz antitelalarning sotilishiga bog'liq bo'lgan kompaniyaning dinamikasini aks ettiradi, bunda joriy ko'rsatkich 0.00 darajasida turibdi.

Checkpoint Therapeutics, Inc (CKPT): Uzoq muddatli qarzning kapitalga nisbati 04.07.2022dan 07.06.2025gacha

CKPT (Checkpoint Therapeutics): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Checkpoint Therapeutics Inc.|CKPT - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Checkpoint Therapeutics, Inc.|CKPT - Kompaniyaning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga xususiy kapital Checkpoint Therapeutics|CKPT - Balans kapitallashuvi|Kapitallashuvning sof aktivlarga nisbati checkpointtx.com|CKPT - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning kapitalga nisbati Checkpoint Therapeutics|CKPT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati checkpointtx.com|CKPT - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Checkpoint Therapeutics, Inc.
Kompaniyaning dastlabki tahlili:CKPT, Checkpoint Therapeutics Inc.
checkpointtx.com brendining mahsuloti

Ushbu ko'rsatkich uzoq muddatli moliyalashtirishning kompaniyaning o'z mablag'lariga qanchalik bog'liqligini belgilaydi. Uzoq muddatli moliyaviy leveraj koeffitsiyentini tahlil qilish orqali investor kapital tuzilmasining barqarorligini baholaydi. Ushbu metrika bir yildan ortiq muddatga ega majburiyatlarning aksiyadorlar kapitaliga nisbati sifatida hisoblanadi. Checkpoint Therapeutics uchun tadqiqotlar davomidagi yuqori naqd pul sarfi tufayli qarzlarning kamligi kritik ahamiyatga ega. Cosibelimab ga tegishli FDA kechiktirishlari xavfi qarz olishdan ko'ra qo'shimcha aksiyalar chiqarish ehtimolini oshiradi.

Raqobatdosh kompaniyalar

Uzoq muddatli qarzning o'z kapitaliga nisbati BeiGene Ltd.|Uzoq muddatli qarzning kapitalga nisbati HALO|Uzoq muddatli qarzning kapitalga nisbati RVMD (Revolution Medicines Corp)|AAPG - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi cgoncology.com CGON|URGN: Uzoq muddatli qarzning kapitalga nisbati|BCAX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati PSNL|ERAS (Erasca Oncology) - Uzoq muddatli majburiyatlarning kapitalga nisbati|DCTH - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti ymabs.com (YMAB)|Aura Biosciences (AURA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti candeltx.com (CADL)|Accuray Inc. - Uzoq muddatli qarzning kapitalga nisbati|SLS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Actuate Therapeutics, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|CTOR: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati tuhurabio.com HURA|Protara Therapeutics Inc (TARA) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati FATE (Fate Therapeutics Corp)|Uzoq muddatli majburiyatlarning kapitalga nisbati Aadi Bio|Uzoq muddatli qarzning kapitalga nisbati TCRX (TScan Therapeutics)|Uzoq muddatli qarzning o'z kapitaliga nisbati championsoncology.com (CSBR)|Uzoq muddatli qarzning kapitalga nisbati XBiotech|Uzoq muddatli qarzning kapitalga koeffitsiyenti CEL-SCI Corp. CVM|OSTX (OS Therapies Inc) - Uzoq muddatli qarzning kapitalga nisbati|RADX - Uzoq muddatli majburiyatlarning kapitalga nisbati|ARTV (artivabio.com) - Uzoq muddatli qarzning kapitalga nisbati|ANL (Adlai Nortye) - Uzoq muddatli qarzning o'z kapitaliga nisbati|VERU (Veru) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati TPST|XLO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati RENB (renovarobio.com)|MURA: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Kairos Pharma Limited KAPA|Uzoq muddatli qarzning kapitalga nisbati OKUR (OnKure)|GDTC: Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati curis.com|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Apollomics|Tharimmune, Inc. (THAR) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli kreditlarning kapitalga nisbati Advanced Biomed Corp (ADVB)|Genprex (GNPX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti calidibio.com CLDI|Uzoq muddatli qarzning o'z kapitaliga nisbati Sunshine Biopharma (SBFM)|Uzoq muddatli kreditlarning kapitalga nisbati Xenetic Biosciences Inc. XBIO|Uzoq muddatli qarzning kapitalga nisbati Salarius Pharmaceuticals (SLRX)|PPBT - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati AONC|BGNE (BeiGene Ltd.) - Uzoq muddatli majburiyatlarning kapitalga nisbati|ELEV - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti iCAD Corp|Uzoq muddatli qarzning kapitalga nisbati IKNA|Uzoq muddatli qarzning kapitalga nisbati NTBL (notablelabs.com)|Viracta Therapeutics, Inc. (VIRX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati MorphoSys Inc MOR|NAYA (NAYA Bio) - Uzoq muddatli qarzning kapitalga nisbati|Ascentage (AAPGV) - Uzoq muddatli majburiyatlarning kapitalga nisbati